A. G. van der Zee
- Oncology top 10%
- Molecular Biology
- Reproductive Medicine top 5%
- Immunology
- Epidemiology
- Co-authors
- Elisabeth G.E. de VriesHarry HollemaH. HollemaJ.G. AaldersToos DaemenW.J. SluiterPax H.B. WillemseMindert Krans
- Topics
- Endometrial and Cervical Cancer Treatments (5 papers)Ovarian cancer diagnosis and treatment (4 papers)Cancer therapeutics and mechanisms (2 papers)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
A. G. van der Zee
15 papers receiving 805 citations
Peers
Comparison fields: 5 of 70
- Oncology 326
- Molecular Biology 290
- Reproductive Medicine 182
- Immunology 162
- Epidemiology 159
Countries citing papers authored by A. G. van der Zee
This map shows the geographic impact of A. G. van der Zee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. G. van der Zee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. G. van der Zee more than expected).
Fields of papers citing papers by A. G. van der Zee
This network shows the impact of papers produced by A. G. van der Zee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. G. van der Zee. The network helps show where A. G. van der Zee may publish in the future.
Co-authorship network of co-authors of A. G. van der Zee
This figure shows the co-authorship network connecting the top 25 collaborators of A. G. van der Zee. A scholar is included among the top collaborators of A. G. van der Zee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. G. van der Zee. A. G. van der Zee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 25 | |
| 3 | 1 | |
| 4 | 72 | |
| 5 | 1 | |
| 6 | 4 | |
| 7 | [The effects of tamoxifen on the female genital tract]. | 3 |
| 8 | 60 | |
| 9 | Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages. | 163 |
| 10 | 5 | |
| 11 | [Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma]. | 1 |
| 12 | 60 | |
| 13 | 128 | |
| 14 | 164 | |
| 15 | Quantitative and qualitative aspects of topoisomerase I and II alpha and beta in untreated and platinum/cyclophosphamide treated malignant ovarian tumors. | 37 |
| 16 | P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide chemotherapy. | 107 |
About A. G. van der Zee
A. G. van der Zee is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Toxicology, having authored 16 papers that have together received 837 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (5 papers), Ovarian cancer diagnosis and treatment (4 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Reproductive Medicine (182 citations), Obstetrics and Gynecology (135 citations) and Oncology (326 citations). A. G. van der Zee has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Elisabeth G.E. de Vries, Harry Hollema, H. Hollema, J.G. Aalders, Toos Daemen, W.J. Sluiter, Pax H.B. Willemse, Mindert Krans, Klaske A. ten Hoor and Steven de Jong. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.